By Karunjit Singh (July 18, 2023, 10:27 AM EDT) -- The Federal Court has dismissed a summary judgment motion brought by a pharmaceutical company which had alleged that a patent invalidity defence claimed by a generic drug manufacturer was res judicata and an abuse of process....